GR930100475A - Φαρμακευτική σύν?εση που περιέχει για γουανιδινο?ειαζολική ένωση και αντιόξινα. - Google Patents

Φαρμακευτική σύν?εση που περιέχει για γουανιδινο?ειαζολική ένωση και αντιόξινα.

Info

Publication number
GR930100475A
GR930100475A GR930100475A GR930100475A GR930100475A GR 930100475 A GR930100475 A GR 930100475A GR 930100475 A GR930100475 A GR 930100475A GR 930100475 A GR930100475 A GR 930100475A GR 930100475 A GR930100475 A GR 930100475A
Authority
GR
Greece
Prior art keywords
pharmaceutical composition
antacids
composition containing
antacid
guanidinothiazole compound
Prior art date
Application number
GR930100475A
Other languages
English (en)
Other versions
GR1002397B (el
Inventor
Susan Decoteau
Eleanor Freeman
Edward J Roche
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25530183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR930100475(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of GR930100475A publication Critical patent/GR930100475A/el
Publication of GR1002397B publication Critical patent/GR1002397B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Μια στερεά μορφή δοσολογίας από του στόματος μιας φαρμακευτικής σύνθεσης για την αγωγή γαστρεντερικών προβλημάτων, η οποία περιλαμβάνει μια θεραπευτικά αποτελεσματική ποσότητα γουανιδινοθειαζόλης ένωσης, και μια θεραπευτικά αποτελεσματική ποσότητα αντιόξινου, όπου το φαρμακευτικό και το αντιόξινου χωρίζονται από φράγμα που είναι βασικά αδιαπέραστο από το αντιόξινο.ω
GR930100475A 1992-12-01 1993-12-01 Φαρμακευτικη συνθεση που περιεχει μια γουανιδινοθειαζολικη ενωση και αντιοξινα. GR1002397B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98392392A 1992-12-01 1992-12-01

Publications (2)

Publication Number Publication Date
GR930100475A true GR930100475A (el) 1994-08-31
GR1002397B GR1002397B (el) 1996-07-12

Family

ID=25530183

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930100475A GR1002397B (el) 1992-12-01 1993-12-01 Φαρμακευτικη συνθεση που περιεχει μια γουανιδινοθειαζολικη ενωση και αντιοξινα.

Country Status (9)

Country Link
US (1) US5817340A (el)
EP (1) EP0600725B1 (el)
AT (1) ATE158176T1 (el)
BR (1) BR1100490A (el)
CA (1) CA2110313C (el)
DE (1) DE69313983T2 (el)
DK (1) DK0600725T3 (el)
ES (1) ES2108234T3 (el)
GR (1) GR1002397B (el)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
DE4444052A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
WO1997019699A1 (fr) * 1995-11-27 1997-06-05 Yamanouchi Pharmaceutical Co., Ltd. Composition de medicament
SE9600071D0 (sv) † 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US5989588A (en) * 1996-10-04 1999-11-23 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
AU728423B2 (en) * 1996-10-04 2001-01-11 Mcneil-Ppc, Inc. Methods and compositions for preventing and treating heartburn
JP3001440B2 (ja) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 仮想ｌａｎ方式
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
AU9187598A (en) * 1997-09-30 1999-04-23 Daiichi Pharmaceutical Co., Ltd. Oral preparation
US6232351B1 (en) * 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
WO2000025754A2 (en) * 1998-11-04 2000-05-11 Mcneil-Ppc, Inc. Solid oral dosage forms containing alginic acid and famotidine
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6793942B2 (en) 2000-02-23 2004-09-21 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6841544B2 (en) * 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6759062B2 (en) 2000-02-23 2004-07-06 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6551617B1 (en) * 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US6998480B2 (en) 2002-03-08 2006-02-14 Tate & Lyle Public Limited Company Process for improving sucralose purity and yield
US7049435B2 (en) 2002-03-08 2006-05-23 Tate & Lyle Public Limited Company Extractive methods for purifying sucralose
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US6663892B1 (en) * 2002-08-19 2003-12-16 L. Perrigo Company Multiple portion tablet
US7713547B2 (en) 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
EP1750647B1 (en) * 2004-05-21 2014-11-19 Accu-Break Technologies, Inc. Pharmaceutical tablets having a separation mark positioned on the side of said tablets
US7838031B2 (en) 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US7780985B2 (en) * 2005-07-12 2010-08-24 Accu-Break Technologies, Inc. Tablets having a printed separation mark to guide breaking
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
KR100714616B1 (ko) * 2005-06-23 2007-05-07 삼성전기주식회사 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
CN100493499C (zh) * 2005-10-14 2009-06-03 四川泰华堂制药有限公司 制备复方法莫替丁咀嚼片的方法
WO2007058660A1 (en) * 2005-11-18 2007-05-24 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US7351853B2 (en) * 2006-01-23 2008-04-01 Albion Advanced Nutrition Method of manufacturing a granular mineral composition
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
WO2007090113A2 (en) 2006-02-01 2007-08-09 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
US8436156B2 (en) * 2008-01-04 2013-05-07 Tate & Lyle Technology Limited Method for the production of sucralose
WO2009095210A1 (en) * 2008-01-31 2009-08-06 Bayer Consumer Care Ag Composition comprising an antacid and a h2-antagonists
WO2009117317A1 (en) * 2008-03-20 2009-09-24 Tate & Lyle Technology Ltd Removal of acids from tertiary amide solvents
US8436157B2 (en) * 2008-03-26 2013-05-07 Tate & Lyle Technology Limited Method for the production of sucralose
CN101981044B (zh) * 2008-04-03 2014-08-06 塔特和莱利技术有限公司 碳水化合物浓度对三氯半乳蔗糖萃取效率的影响
US8497367B2 (en) * 2008-04-03 2013-07-30 Tate & Lyle Technology Limited Sucralose purification process
WO2009124113A1 (en) * 2008-04-03 2009-10-08 Tate & Lyle Technology Ltd. Extraction of less polar impurities from sucralose containing aqueous feed streams
AR071134A1 (es) * 2008-04-03 2010-05-26 Tate & Lyle Technology Ltd Cristalizacion de sucralosa a partir de chorros que contienen sucralosa
EP2344139A1 (en) * 2008-09-09 2011-07-20 AstraZeneca AB Method for delivering a pharmaceutical composition to patient in need thereof
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
CA2750196C (en) * 2009-01-05 2017-06-20 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US8377475B2 (en) * 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
GB2469158B (en) 2009-03-31 2011-09-28 Peter J Seaberg Base-assisted formation of tin-sucrose adducts
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB2474310B (en) 2009-10-12 2012-02-29 Tate & Lyle Technology Ltd Process for the production of sucrose-6-ester
GB2474311B (en) * 2009-10-12 2012-10-17 Tate & Lyle Technology Ltd Low temperature, single solvent process for the production of sucrose-6-ester
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
GB201110520D0 (en) 2011-05-10 2011-08-03 Tate & Lyle Technology Ltd Extraction of carboxylic acids with tin compounds
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CN104906057B (zh) * 2015-05-29 2018-03-02 西南药业股份有限公司 法莫替丁钙镁微丸型咀嚼片的制备方法及其产品
CN104971073B (zh) * 2015-05-29 2018-01-12 西南药业股份有限公司 法莫替丁钙镁咀嚼片的制备方法及其产品
WO2017091166A1 (en) 2015-11-26 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Stable pharmaceutical compositions and process for their preparation
EP3389628A4 (en) 2015-12-19 2019-08-07 Dixit, Manesh A. PHARMACEUTICAL FORMULATIONS OF MOUSE CHEESE TABLETS
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
EP3784214A4 (en) * 2018-04-27 2022-01-19 Johnson & Johnson Consumer Inc. LIQUID ORAL PHARMACEUTICAL DOSAGE FORM
EP3866770A1 (en) 2018-10-18 2021-08-25 Johnson & Johnson Consumer Inc. Novel dosage form
KR102484953B1 (ko) * 2020-06-25 2023-01-06 주식회사 인트로바이오파마 파모티딘, 수산화마그네슘, 및 침강탄산칼슘을 유효성분으로 하는 위장질환 치료용 필름코팅정제
CN112294841A (zh) * 2020-10-21 2021-02-02 北京鑫开元医药科技有限公司 一种法莫替丁枸橼酸铋钾复方组合物、制备方法及其应用
EP4312992A1 (en) 2021-03-24 2024-02-07 Johnson & Johnson Consumer Inc. A pharmaceutical composition comprising famotidine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
FR2236483B1 (el) * 1973-07-12 1976-11-12 Choay Sa
US4198390A (en) * 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
ATE73328T1 (de) * 1987-05-08 1992-03-15 Smith Kline French Lab Pharmazeutische zusammensetzungen.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
AU7981391A (en) * 1990-06-22 1992-01-23 Beecham Group Plc Novel treatment
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
BR1100490A (pt) 2000-06-13
US5817340A (en) 1998-10-06
DE69313983T2 (de) 1998-02-19
CA2110313A1 (en) 1994-06-02
CA2110313C (en) 2004-10-26
DK0600725T3 (da) 1998-03-16
EP0600725B1 (en) 1997-09-17
EP0600725A1 (en) 1994-06-08
ES2108234T3 (es) 1997-12-16
ATE158176T1 (de) 1997-10-15
DE69313983D1 (de) 1997-10-23
GR1002397B (el) 1996-07-12

Similar Documents

Publication Publication Date Title
GR930100475A (el) Φαρμακευτική σύν?εση που περιέχει για γουανιδινο?ειαζολική ένωση και αντιόξινα.
GR930100197A (el) Νέες φαρμακευτικές συν?έσεις που περιέχουν σιμε?εικόνη.
IL60114A0 (en) Pharmaceutical compositions for transdermal application in the form of a polyacrylate film
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
SE8300736D0 (sv) Novel pharmacologically active compounds
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
KR910009273A (ko) 위장관계 통증 치료용 약제학적 조성물
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
DK157482A (da) Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf
SE8703632D0 (sv) Sustained release fluoride composition
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
EP0578643A4 (en) CONNECTION AND PHARMACEUTICAL COMPOSITION FOR TREATING CALCIUM OXALATE STONE DISEASE.
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
KR830009776A (ko) 세포 보호 유도방법
EP0093497A3 (en) Anthelmintic treatment
MX9205454A (es) Composicion farmaceutica para administracion oral al tracto gastrointestinal que comprende calcitonina
DE3689254D1 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
ATE157250T1 (de) Wismutsubsalicylat in form einer einheitsdosis
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
RO113805B1 (ro) Medicament pentru tratamentul ulcerului gastro-duodenal şi gastritei cronice

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees